CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-12 | HIGGINS JOHN L Director | Option exercise | +6,000 | $22.95 | $138K | 48,608 |
| 2024-09-12 | HIGGINS JOHN L Director | Shares withheld for taxes | −1,874 | $73.20 | $137K | 46,734 |
| 2024-09-12 | HIGGINS JOHN L Director | Option exercise · Stock Options (Right to Buy) | −6,000 | 0 | ||
| 2024-08-29 | Kelderman Kim Chief Executive Officer | Option exercise | +1,492 | $66.97 | $100K | 41,434 |
| 2024-08-29 | Kelderman Kim Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −1,492 | 115,724 | ||
| 2024-08-15 | McManus Matthew President - DGS | Grant or award · Performance Restricted Stock Units | +15,825 | 15,825 | ||
| 2024-08-15 | Hippel James CFO | Grant or award · Performance Restricted Stock Units | +24,062 | 24,062 | ||
| 2024-08-15 | Hippel James CFO | Grant or award · Restricted Stock Units | +12,031 | 12,031 | ||
| 2024-08-15 | Hippel James CFO | Grant or award · Stock Options (Right to Buy) | +32,417 | 32,417 | ||
| 2024-08-15 | Kelderman Kim Chief Executive Officer | Grant or award · Performance Restricted Stock Units | +51,261 | 51,261 | ||
| 2024-08-15 | Kelderman Kim Chief Executive Officer | Grant or award · Restricted Stock Units | +25,630 | 25,630 | ||
| 2024-08-15 | Kelderman Kim Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +69,061 | 69,061 | ||
| 2024-08-15 | Geist William PRESIDENT, PROTEIN SCIENCES | Grant or award · Performance Restricted Stock Units | +15,738 | 15,738 | ||
| 2024-08-15 | Geist William PRESIDENT, PROTEIN SCIENCES | Grant or award · Restricted Stock Units | +7,869 | 7,869 | ||
| 2024-08-15 | Geist William PRESIDENT, PROTEIN SCIENCES | Grant or award · Stock Options (Right to Buy) | +21,204 | 21,204 | ||
| 2024-08-15 | Bohnen Shane SVP - General Counsel | Option exercise | +49 | 1,696 | ||
| 2024-08-15 | Bohnen Shane SVP - General Counsel | Shares withheld for taxes | −15 | $74.91 | $1K | 1,681 |
| 2024-08-15 | Bohnen Shane SVP - General Counsel | Option exercise · Restricted Stock Units | −49 | 99 | ||
| 2024-08-15 | Bohnen Shane SVP - General Counsel | Grant or award · Performance Restricted Stock Units | +10,012 | 10,012 | ||
| 2024-08-15 | Bohnen Shane SVP - General Counsel | Grant or award · Restricted Stock Units | +5,006 | 5,006 |
Page 15 of 32 · 626 trades